In one paragraphArticle in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
17 authors.
Dragana VukićCentral European Institute for Technology at Masaryk University (CEITEC MU), Building E35, Kamenice 735/5, 625 00 Brno, Czech Republic.ORCID 0000-0001-9272-728X Qiupei DuCentral European Institute for Technology at Masaryk University (CEITEC MU), Building E35, Kamenice 735/5, 625 00 Brno, Czech Republic.ORCID 0009-0002-8048-625X Anna CherianCentral European Institute for Technology at Masaryk University (CEITEC MU), Building E35, Kamenice 735/5, 625 00 Brno, Czech Republic.ORCID 0000-0003-1072-3440 Damiano AmorusoCentral European Institute for Technology at Masaryk University (CEITEC MU), Building E35, Kamenice 735/5, 625 00 Brno, Czech Republic.ORCID 0009-0000-7290-8390 Květoslava BrožinováCentral European Institute for Technology at Masaryk University (CEITEC MU), Building E35, Kamenice 735/5, 625 00 Brno, Czech Republic.
Ludivine WacheulRNA Molecular Biology, Fonds de la Recherche Scientifique (F.R.S./FNRS), Université libre de Bruxelles (ULB), Biopark campus, B-6041 Gosselies, Belgium.ORCID 0000-0002-0443-8865 Valentina LacovichCentral European Institute for Technology at Masaryk University (CEITEC MU), Building E35, Kamenice 735/5, 625 00 Brno, Czech Republic.ORCID 0000-0003-3280-4583 Christiane ZorbasRNA Molecular Biology, Fonds de la Recherche Scientifique (F.R.S./FNRS), Université libre de Bruxelles (ULB), Biopark campus, B-6041 Gosselies, Belgium.ORCID 0000-0002-1861-3644 Leena YadavInstitute of Biotechnology, HiLIFE Helsinki Institute of Life Science, University of Helsinki, Viikinkaari 1, 00790 Helsinki, Finland.
Jiří SedmíkCentral European Institute for Technology at Masaryk University (CEITEC MU), Building E35, Kamenice 735/5, 625 00 Brno, Czech Republic.ORCID 0000-0002-5589-1061 Salla KeskitaloInstitute of Biotechnology, HiLIFE Helsinki Institute of Life Science, University of Helsinki, Viikinkaari 1, 00790 Helsinki, Finland.
Khadija HajjiCentral European Institute for Technology at Masaryk University (CEITEC MU), Building E35, Kamenice 735/5, 625 00 Brno, Czech Republic.ORCID 0009-0002-8420-4467 Stanislav StejskalCentral European Institute for Technology at Masaryk University (CEITEC MU), Building E35, Kamenice 735/5, 625 00 Brno, Czech Republic.
Markku VarjosaloInstitute of Biotechnology, HiLIFE Helsinki Institute of Life Science, University of Helsinki, Viikinkaari 1, 00790 Helsinki, Finland.ORCID 0000-0002-1340-9732 Denis L J LafontaineRNA Molecular Biology, Fonds de la Recherche Scientifique (F.R.S./FNRS), Université libre de Bruxelles (ULB), Biopark campus, B-6041 Gosselies, Belgium.ORCID 0000-0001-7295-6288 Liam P KeeganCentral European Institute for Technology at Masaryk University (CEITEC MU), Building E35, Kamenice 735/5, 625 00 Brno, Czech Republic.ORCID 0000-0001-7915-5790 Mary A O'ConnellCentral European Institute for Technology at Masaryk University (CEITEC MU), Building E35, Kamenice 735/5, 625 00 Brno, Czech Republic.ORCID 0000-0003-3844-6174 Funding
Academy of Finland 288475Belgian Fonds de la Recherche Scientifique (F.R.S.-FNRS) 40007512COST Action TRANSLACORE CA21154Czech Science Foundation 21-27329XCzech Science Foundation GAČREuropean Joint Programme on Rare Diseases (EJP-RD): RiboEurope and DBAGeneCure 288475Finnish Cancer FoundationMarie Skłodowska-Curie Actions Doctoral Network (MSCA-DN) EURECA 288475Région Wallonne (SPW EER) Win4SpinOff (RIBOGENESIS) CA21154Sigrid Jusélius Foundation
6 · The paper itselfAbstract
The adenosine deaminase acting on RNA (ADAR) enzymes deaminate adenosine to inosine in double-stranded (ds)RNA. Mammals express two catalytically active enzymes: ADAR1, which is ubiquitously expressed and essential for innate immune homeostasis, and ADAR2, which is enriched in the brain and vascular system. Here, we investigate the ADAR2 interactome and uncover a shared interaction network with ADAR1, including multiple components of the RNA exosome complex, a multi-subunit RNase involved in RNA processing, turnover, and surveillance. The interactions between ADARs and RNA exosome components are nuclear, and resistance to RNase A treatment implies their close proximity. We validated these interactions by immunoprecipitation of both endogenous and epitope-tagged ADAR proteins in multiple cell lines and mapped the interaction interfaces to their dsRNA-binding domains. Exploiting an MS2-MCP tethering system, we show that recruitment of ADAR1 or ADAR2 to the 3' UTR of a reporter transcript decreases its stability. This decrease in RNA levels was reversed when EXOSC3 was depleted, demonstrating that this destabilizing effect of ADARs on RNA is via the RNA exosome complex. Finally, knockdown of ADARs perturbs rRNA processing, a canonical function of the nuclear exosome, demonstrating a cellular consequence of disrupting ADAR-exosome interactions.
Indexed as
Adenosine DeaminaseExosome Multienzyme Ribonuclease ComplexRNA-Binding ProteinsRNA Stability3' Untranslated RegionsAnimalsCell LineExosomesHEK293 CellsHumansProtein BindingRNA, Double-Stranded3' Untranslated RegionsADARB1 protein, humanADAR protein, humanAdenosine DeaminaseExosome Multienzyme Ribonuclease ComplexRNA-Binding ProteinsRNA, Double-Stranded
Identifiers
PMID42033221
PMCPMC13107131
What Socratic holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390